BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cholankeril G, Patel R, Khurana S, Satapathy SK. Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management. World J Hepatol 2017; 9(11): 533-543 [PMID: 28469809 DOI: 10.4254/wjh.v9.i11.533]
URL: https://www.wjgnet.com/1948-5182/full/v9/i11/533.htm
Number Citing Articles
1
Gehad A. Abdel Jaleel, Sally A. Al-Awdan, Rania F. Ahmed, Omar A.H. Ahmed-Farid, Dalia O. Saleh. Melatonin regulates neurodegenerative complications associated with NAFLD via enhanced neurotransmission and cellular integrity: a correlational studyMetabolic Brain Disease 2020; 35(8): 1251 doi: 10.1007/s11011-020-00593-4
2
Yoshio Shimizu, Takafumi Tamura, Akira Kemmochi, Yohei Owada, Yusuke Ozawa, Katsuji Hisakura, Takashi Matsuzaka, Hitoshi Shimano, Noriyuki Nakano, Shingo Sakashita, Tatsuya Oda, Nobuhiro Ohkohchi. Oxidative stress and Liver X Receptor agonist induce hepatocellular carcinoma in Non‐alcoholic steatohepatitis modelJournal of Gastroenterology and Hepatology 2021; 36(3): 800 doi: 10.1111/jgh.15239
3
Rashmi Pathak, Avinash Kumar. Post-Transcriptional Gene Regulation in Human Disease2022; : 255 doi: 10.1016/B978-0-323-91305-8.00003-X
4
Tyler L. Bissoondial, Anthony J. Pellicano, Itzhak D. Goldberg, Prakash Narayan. Identification of disease-associated microRNA in a diet-induced model of nonalcoholic steatohepatitisMolecular Omics 2021; 17(6): 911 doi: 10.1039/D1MO00274K
5
Pratima Dibba, Andrew Li, George Cholankeril, Umair Iqbal, Chiranjeevi Gadiparthi, Muhammad Khan, Donghee Kim, Aijaz Ahmed. Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver DiseaseMedicines 2018; 5(2): 47 doi: 10.3390/medicines5020047
6
Naga Swetha Samji, Rajanshu Verma, Krishna Chaitanya Keri, Ashwani K. Singal, Aijaz Ahmed, Mary Rinella, David Bernstein, Manal F. Abdelmalek, Sanjaya K. Satapathy. Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical ChallengesDigestive Diseases and Sciences 2019; 64(12): 3413 doi: 10.1007/s10620-019-05716-1
7
Eman A. Ahmed, Marwa O. El-Derany, Ali Mostafa Anwar, Essa M. Saied, Sameh Magdeldin. Metabolomics and Lipidomics Screening Reveal Reprogrammed Signaling Pathways toward Cancer Development in Non-Alcoholic SteatohepatitisInternational Journal of Molecular Sciences 2022; 24(1): 210 doi: 10.3390/ijms24010210
8
Tyler L. Bissoondial, Yiguang Han, Stephanie Mullan, Amrit K. Pabla, Kiera Spahn, Steven Shi, Lana Zheng, Ping Zhou, Kai Jiang, Natalia Prakash, Shraddha Bhutkar, Quaisar Ali, Jingsong Li, Zhijian Hu, Anthony J. Pellicano, Itzhak D. Goldberg, Prakash Narayan. Liver Biopsy Hydroxyproline Content Is a Diagnostic for Hepatocellular Carcinoma in Murine Models of Nonalcoholic SteatohepatitisDiagnostics 2020; 10(10): 784 doi: 10.3390/diagnostics10100784
9
Anthony J. Pellicano, Stephanie Mullan, Itzhak D. Goldberg, Prakash Narayan. Hepatic mRNA Expression Levels of the Oncogenes Alpha-Fetoprotein and Osteopontin as Diagnostics for Liver Cancer in a Murine Model of Diet-Induced Non-Alcoholic SteatohepatitisProcesses 2021; 9(9): 1516 doi: 10.3390/pr9091516
10
Catherine T. Frenette, Ari J. Isaacson, Irene Bargellini, Sammy Saab, Amit G. Singal. A Practical Guideline for Hepatocellular Carcinoma Screening in Patients at RiskMayo Clinic Proceedings: Innovations, Quality & Outcomes 2019; 3(3): 302 doi: 10.1016/j.mayocpiqo.2019.04.005
11
Simon Haefliger, Dina Milowich, Amedeo Sciarra, Mounir Trimeche, Justine Bouilly, Julie Kaiser, Stephanie Volpi, Jean-Philippe Brouland, Christine Sempoux, Laurence de Leval. Primary hepatic marginal B cell lymphoma of mucosa-associated lymphoid tissue (MALT) and non-alcoholic steatohepatitis (NASH): more than a coincidence?Annals of Hematology 2019; 98(6): 1513 doi: 10.1007/s00277-018-3565-5
12
Daniela Gabbia, Luana Cannella, Sara De Martin. The Role of Oxidative Stress in NAFLD–NASH–HCC Transition—Focus on NADPH OxidasesBiomedicines 2021; 9(6): 687 doi: 10.3390/biomedicines9060687
13
Jorge Gutiérrez-Cuevas, Silvia Lucano-Landeros, Daniel López-Cifuentes, Arturo Santos, Juan Armendariz-Borunda. Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic StrategiesCancers 2022; 15(1): 23 doi: 10.3390/cancers15010023
14
Scott L. Friedman, Arun J. Sanyal. The future of hepatologyHepatology 2023;  doi: 10.1097/HEP.0000000000000389
15
Takaaki Izumi, Takuya Sho, Kenichi Morikawa, Taku Shigesawa, Kazuharu Suzuki, Akihisa Nakamura, Masatsugu Ohara, Naoki Kawagishi, Machiko Umemura, Tomoe Shimazaki, Megumi Kimura, Masato Nakai, Goki Suda, Mitsuteru Natsuizaka, Koji Ogawa, Yusuke Kudo, Mutsumi Nishida, Kota Ono, Masaru Baba, Ken Furuya, Naoya Sakamoto. Assessing the risk of hepatocellular carcinoma by combining liver stiffness and the controlled attenuation parameterHepatology Research 2019; 49(10): 1207 doi: 10.1111/hepr.13391
16
Maria Teresa Guagnano, Damiano D'Ardes, Rossi Ilaria, Francesca Santilli, Cosima Schiavone, Marco Bucci, Francesco Cipollone. Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome in Women: Effects of Lifestyle ModificationsJournal of Clinical Medicine 2022; 11(10): 2759 doi: 10.3390/jcm11102759
17
Karthik Balakrishnan. Hepatocellular carcinoma stage: an almost loss of fatty acid metabolism and gain of glucose metabolic pathways dysregulationMedical Oncology 2022; 39(12) doi: 10.1007/s12032-022-01839-0
18
Tianpeng Zhang, Junjie Hu, Xiaomei Wang, Xiaoling Zhao, Zhuoyu Li, Junqi Niu, Clifford J. Steer, Guohua Zheng, Guisheng Song. MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-κB-TNFα pathwayJournal of Hepatology 2019; 70(1): 87 doi: 10.1016/j.jhep.2018.08.026
19
Pradeep K. Siddappa, John W. Birk. Healthy Aging2019; : 67 doi: 10.1007/978-3-030-06200-2_7
20
Mélissa Léveillé, Jennifer L. Estall. Mitochondrial Dysfunction in the Transition from NASH to HCCMetabolites 2019; 9(10): 233 doi: 10.3390/metabo9100233
21
LiKang Chin, Neil D. Theise, Abigail E. Loneker, Paul A. Janmey, Rebecca G. Wells. Lipid droplets disrupt mechanosensing in human hepatocytesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 319(1): G11 doi: 10.1152/ajpgi.00098.2020
22
Jelena Krstic, Markus Galhuber, Tim Schulz, Michael Schupp, Andreas Prokesch. p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the MedicineInternational Journal of Molecular Sciences 2018; 19(3): 921 doi: 10.3390/ijms19030921
23
Ahmed Ayyash, Alison C. Holloway. Fluoxetine‐induced hepatic lipid accumulation is mediated by prostaglandin endoperoxide synthase 1 and is linked to elevated 15‐deoxy‐Δ 12,14 PGJ 2 Journal of Applied Toxicology 2022; 42(6): 1004 doi: 10.1002/jat.4272
24
Edda Russo, Camila Fiorindi, Francesco Giudici, Amedeo Amedei. Immunomodulation by probiotics and prebiotics in hepatocellular carcinomaWorld Journal of Hepatology 2022; 14(2): 372-385 doi: 10.4254/wjh.v14.i2.372
25
Utibe-Abasi Udoh, Juan D Sanabria, Pradeep K Rajan, Moumita Banerjee, Mathew Schade, Jacqueline A Sanabria, Gary Smith, Gideon Udoh, Komal Sodhi, Sandrine Pierre, Joseph I Shapiro, Juan R Sanabria. Liver Cancer2021; : 55 doi: 10.36255/exonpublications.livercancer.2021.ch3
26
Konstantinos Arvanitakis, Theocharis Koufakis, Kalliopi Kotsa, Georgios Germanidis. The effects of sodium-glucose cotransporter 2 inhibitors on hepatocellular carcinoma: From molecular mechanisms to potential clinical implicationsPharmacological Research 2022; 181: 106261 doi: 10.1016/j.phrs.2022.106261
27
Edison Roberto PARISE. NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), MORE THAN A LIVER DISEASEArquivos de Gastroenterologia 2019; 56(3): 243 doi: 10.1590/s0004-2803.201900000-45
28
Emma Henriksson, Birgitte Andersen. FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to HumanFrontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.601349
29
Paul Kubes, Craig Jenne. Immune Responses in the LiverAnnual Review of Immunology 2018; 36(1): 247 doi: 10.1146/annurev-immunol-051116-052415
30
Youxi Yu, Xiaoju Shi, Xingtong Wang, Ping Zhang, Ou Bai, Yan Li. Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseasesCell & Bioscience 2022; 12(1) doi: 10.1186/s13578-022-00763-0
31
Michael Kram. Galectin-3 inhibition as a potential therapeutic target in non-alcoholic steatohepatitis liver fibrosisWorld Journal of Hepatology 2023; 15(2): 201-207 doi: 10.4254/wjh.v15.i2.201
32
Molood Bagherieh, Asma Kheirollahi, Fahimeh Zamani-Garmsiri, Solaleh Emamgholipour, Reza Meshkani. Folic acid ameliorates palmitate-induced inflammation through decreasing homocysteine and inhibiting NF-κB pathway in HepG2 cellsArchives of Physiology and Biochemistry 2021; : 1 doi: 10.1080/13813455.2021.1878539
33
Lionel Fizanne, Alexandre Villard, Nadia Benabbou, Sylvain Recoquillon, Raffaella Soleti, Erwan Delage, Mireille Wertheimer, Xavier Vidal‐Gómez, Thibauld Oullier, Samuel Chaffron, M. Carmen Martínez, Michel Neunlist, Jérôme Boursier, Ramaroson Andriantsitohaina. Faeces‐derived extracellular vesicles participate in the onset of barrier dysfunction leading to liver diseasesJournal of Extracellular Vesicles 2023; 12(2): 12303 doi: 10.1002/jev2.12303
34
Mayank Jain, Jayanthi Venkataraman, Joy Varghese, Mukul Vij, Mettu S Reddy, Mohamed Rela. Explant liver evaluation decodes the mystery of cryptogenic cirrhosis!JGH Open 2020; 4(1): 39 doi: 10.1002/jgh3.12200
35
Mohamed A. Nasr, Radwa Ayman Salah, M. Abd Elkodous, Shimaa E. Elshenawy, Nagwa El-Badri. Dysregulated MicroRNA Fingerprints and Methylation Patterns in Hepatocellular Carcinoma, Cancer Stem Cells, and Mesenchymal Stem CellsFrontiers in Cell and Developmental Biology 2019; 7 doi: 10.3389/fcell.2019.00229
36
Ryo Yamauchi, Hidetoshi Takedatsu, Keiji Yokoyama, Eri Yamauchi, Motoko Kawashima, Takahiro Nagata, Yotaro Uchida, Takanori Kitaguchi, Tomotaka Higashi, Hiromi Fukuda, Naoaki Tsuchiya, Kazuhide Takata, Takashi Tanaka, Daisuke Morihara, Yasuaki Takeyama, Satoshi Shakado, Shotaro Sakisaka, Fumihito Hirai. Elobixibat, an ileal bile acid transporter inhibitor, ameliorates non-alcoholic steatohepatitis in miceHepatology International 2021; 15(2): 392 doi: 10.1007/s12072-020-10107-0
37
Alexandre Villard, Jérôme Boursier, Ramaroson Andriantsitohaina. Bacterial and eukaryotic extracellular vesicles and nonalcoholic fatty liver disease: new players in the gut-liver axis?American Journal of Physiology-Gastrointestinal and Liver Physiology 2021; 320(4): G485 doi: 10.1152/ajpgi.00362.2020
38
Priyankar Dey, Joshua B. Kim, Chureeporn Chitchumroonchokchai, Jinhui Li, Geoffrey Y. Sasaki, Bryan D. Olmstead, Katie L. Stock, Jennifer M. Thomas-Ahner, Steven K. Clinton, Richard S. Bruno. Green tea extract inhibits early oncogenic responses in mice with nonalcoholic steatohepatitisFood & Function 2019; 10(10): 6351 doi: 10.1039/C9FO01199D
39
I. Glory Josephine, K. Punnagai. In Vitro Cytotoxicity Activity of Ethanolic Leaf Extract of Costus Igneus Against Hepatocellular Carcinoma (HepG2) CellsBiomedical and Pharmacology Journal 2019; 12(2): 901 doi: 10.13005/bpj/1715
40
Utibe-Abasi S. Udoh, Moumita Banerjee, Pradeep K. Rajan, Juan D. Sanabria, Gary Smith, Mathew Schade, Jacqueline A. Sanabria, Yuto Nakafuku, Komal Sodhi, Sandrine V. Pierre, Joseph I. Shapiro, Juan R. Sanabria. Tumor-Suppressor Role of the α1-Na/K-ATPase Signalosome in NASH Related Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2022; 23(13): 7359 doi: 10.3390/ijms23137359
41
S. M. Touhidul Islam, Arun P. Palanisamy, Gabriel R. Chedister, Michael G. Schmidt, David N. B. Lewin, Kenneth D. Chavin, Wan-Long Chuang. Unsaturated or saturated dietary fat-mediated steatosis impairs hepatic regeneration following partial hepatectomy in micePLOS ONE 2023; 18(5): e0284428 doi: 10.1371/journal.pone.0284428
42
Bianca M. Arendt, Anastasia Teterina, Paulina Pettinelli, Elena M. Comelli, David W.L. Ma, Scott K. Fung, Ian D. McGilvray, Sandra E. Fischer, Johane P. Allard. Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver diseaseNutrition 2019; 62: 100 doi: 10.1016/j.nut.2018.12.001
43
A. T. Billeter, B. P. Müller-Stich. Metabolische ChirurgieDer Chirurg 2019; 90(2): 157 doi: 10.1007/s00104-018-0786-z
44
Zulqar Islam, Brett Hausauer, Jayanth Keshavamurthy, Darko Pucar. Rapidly Lethal Ruptured Hepatocellular Carcinoma With Disseminated Peritoneal Carcinomatosis on FDG PET/CTClinical Nuclear Medicine 2019; 44(11): e622 doi: 10.1097/RLU.0000000000002650
45
Anne Hwang, Christopher Shi, Edward Zhu, Farha Naaz, Ping Zhou, Zainab Rasheed, Michelle Liu, Lindsey S. Jung, Bin Duan, Jingsong Li, Kai Jiang, Latha Paka, Satishkumar V. Gadhiya, Dibyendu Dana, Quaisar Ali, Michael A. Yamin, Itzhak D. Goldberg, Prakash Narayan, Mahesh Narayan. Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASHPLOS ONE 2018; 13(6): e0198937 doi: 10.1371/journal.pone.0198937
46
Monica Lupsor-Platon, Teodora Serban, Alexandra-Iulia Silion, Alexandru Tirpe, Mira Florea. Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Step Forward for Better Evaluation Using Ultrasound ElastographyCancers 2020; 12(10): 2778 doi: 10.3390/cancers12102778
47
Zaki A. Sherif. Nonalcoholic Fatty Liver Disease - An Update2019;  doi: 10.5772/intechopen.85780
48
Lydie Carreres, Zuzana Macek Jílková, Guillaume Vial, Patrice N. Marche, Thomas Decaens, Hervé Lerat. Modeling Diet-Induced NAFLD and NASH in Rats: A Comprehensive ReviewBiomedicines 2021; 9(4): 378 doi: 10.3390/biomedicines9040378
49
Marina Cecilia Vera, María Eugenia Biancardi, Hebe Bottai, María Cristina Lugano, Ariel Darío Quiroga, Gerardo Bruno Pisani, Alejandra Beatriz Quintana. First approaches for the transplantation of hepatocytes from Wistar rat preneoplastic livers into healthy recipientsRevista Española de Enfermedades Digestivas 2019;  doi: 10.17235/reed.2019.5830/2018
50
Hang Yin, Anhua Shi, Junzi Wu. Platelet-Activating Factor Promotes the Development of Non-Alcoholic Fatty Liver DiseaseDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; : 2003 doi: 10.2147/DMSO.S367483
51
Marius Farcas, Andrei-Alexandru Gavrea, Diana Gulei, Calin Ionescu, Alexandru Irimie, Cristina S. Catana, Ioana Berindan-Neagoe. SIRT1 in the Development and Treatment of Hepatocellular CarcinomaFrontiers in Nutrition 2019; 6 doi: 10.3389/fnut.2019.00148
52
Madunil A. Niriella, Uditha Dassanayake, Hithanadura J. de Silva. ‘Mistakes in managing non-alcoholic fatty liver disease and how to avoid them’Scandinavian Journal of Gastroenterology 2023; 58(3): 223 doi: 10.1080/00365521.2022.2123252
53
Zobair M. Younossi, Radhika P. Tampi, Fatema Nader, Issah M. Younossi, Rebecca Cable, Manirath Srishord, Andrei Racila. Hypothetical treatment of patients with non‐alcoholic steatohepatitis: Potential impact on important clinical outcomesLiver International 2020; 40(2): 308 doi: 10.1111/liv.14292
54
H. Taflin, L. Hafström, E. Holmberg, M. Castedal, P. Lindnér. The impact of increased immigration to Sweden on the incidence and treatment of patients with HCC and underlying liver diseaseScandinavian Journal of Gastroenterology 2019; 54(6): 746 doi: 10.1080/00365521.2019.1627580
55
Salem Alsaqal, Paul Hockings, Håkan Ahlström, Anders Gummesson, Anders Hedström, Johannes Hulthe, Lars Johansson, Heiko G. Niessen, Corinna Schoelch, Christian Schultheis, Johan Vessby, Alkwin Wanders, Fredrik Rorsman, Charlotte Ebeling Barbier. The Combination of MR Elastography and Proton Density Fat Fraction Improves Diagnosis of Nonalcoholic Steatohepatitis Journal of Magnetic Resonance Imaging 2022; 56(2): 368 doi: 10.1002/jmri.28040
56
Yedidya Saiman, Andres Duarte-Rojo, Mary E. Rinella. Fatty Liver Disease: Diagnosis and StratificationAnnual Review of Medicine 2022; 73(1): 529 doi: 10.1146/annurev-med-042220-020407
57
Andra-Iulia Suceveanu, Laura Mazilu, Andreea-Daniela Gheorghe, Anca Pantea Stoian, Felix Voinea, Adrian-Paul Suceveanu. Liver Cancer2018;  doi: 10.5772/intechopen.80527
58
Ozlem Kucukoglu, Jan-Peter Sowa, Guillermo Daniel Mazzolini, Wing-Kin Syn, Ali Canbay. Hepatokines and adipokines in NASH-related hepatocellular carcinomaJournal of Hepatology 2021; 74(2): 442 doi: 10.1016/j.jhep.2020.10.030
59
Gabriel Scarlat, Bassil Dona, Mihai Cârstea, Marilena Stoian. Insights into Non-Alcoholic Fatty Liver Disease and Non-Alcoholic SteatohepatitisInternal Medicine 2022; 19(1): 61 doi: 10.2478/inmed-2022-0198
60
Melissa Yepmo, Jean-Baptiste Potier, Michel Pinget, Anastasia Grabarz, Karim Bouzakri, Aurore Dumond Bourie. Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complicationsFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1035159
61
Talhah Zubair, Timothy Yen, Gordon Gao. Solitary Extrahepatic Intramuscular Metastasis from Cryptogenic Hepatocellular CarcinomaACG Case Reports Journal 2018; 5(1): e64 doi: 10.14309/crj.2018.64
62
Atsushi Oyama, Kazuhiro Nouso, Kenichi Yoshimura, Yuki Morimoto, Shinichiro Nakamura, Hideki Onishi, Akinobu Takaki, Shouta Iwadou, Kazuya Kariyama, Kenji Kuwaki, Kazuhisa Yabushita, Kosaku Sakaguchi, Jyunichi Toshimori, Haruhiko Kobashi, Akio Moriya, Masaharu Ando, Hiroyuki Okada. Randomized controlled study to examine the efficacy of hepatic arterial infusion chemotherapy with cisplatin before radiofrequency ablation for hepatocellular carcinomaHepatology Research 2021; 51(6): 694 doi: 10.1111/hepr.13633
63
Ivana Milosevic, Ankica Vujovic, Aleksandra Barac, Marina Djelic, Milos Korac, Aleksandra Radovanovic Spurnic, Ivana Gmizic, Olja Stevanovic, Vladimir Djordjevic, Nebojsa Lekic, Edda Russo, Amedeo Amedei. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the LiteratureInternational Journal of Molecular Sciences 2019; 20(2): 395 doi: 10.3390/ijms20020395
64
George Cholankeril, Hashem B. El-Serag. Current Challenges and Future Direction in Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver DiseaseSeminars in Liver Disease 2023; 43(01): 089 doi: 10.1055/a-1957-8540
65
Liang Meng Loy, Hsien Min Low, Jin-Young Choi, Hyungjin Rhee, Chin Fong Wong, Cher Heng Tan. Variant Hepatocellular Carcinoma Subtypes According to the 2019 WHO Classification: An Imaging-Focused ReviewAmerican Journal of Roentgenology 2022; 219(2): 212 doi: 10.2214/AJR.21.26982
66
Laura Antonucci, Cristiana Porcu, Eleonora Timperi, Silvano Junior Santini, Gino Iannucci, Clara Balsano. Circulating Neutrophils of Nonalcoholic Steatohepatitis Patients Show an Activated Phenotype and Suppress T Lymphocytes ActivityJournal of Immunology Research 2020; 2020: 1 doi: 10.1155/2020/4570219
67
R. Leela-arporn, H. Ohta, N. Nagata, K. Sasaoka, M. Tamura, A. Dermlim, K. Nisa, K. Morishita, N. Sasaki, K. Nakamura, S. Takagi, K. Hosoya, M. Takiguchi. Epidemiology of massive hepatocellular carcinoma in dogs: A 4-year retrospective studyThe Veterinary Journal 2019; 248: 74 doi: 10.1016/j.tvjl.2019.04.011
68
Naga S. Samji, Rajanshu Verma, Sanjaya K. Satapathy. Magnitude of Nonalcoholic Fatty Liver Disease: Western PerspectiveJournal of Clinical and Experimental Hepatology 2019; 9(4): 497 doi: 10.1016/j.jceh.2019.05.001
69
Chunye Zhang, Shuai Liu, Ming Yang. The Role of Interferon Regulatory Factors in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic SteatohepatitisGastroenterology Insights 2022; 13(2): 148 doi: 10.3390/gastroent13020016
70
Minhee Lee, Dakyung Kim, So Jung Park, Kyung Seok Kim, Geum Duck Park, Ok-Kyung Kim, Jeongmin Lee. Artichoke Extract Directly Suppresses Inflammation and Apoptosis in Hepatocytes During the Development of Non-Alcoholic Fatty Liver DiseaseJournal of Medicinal Food 2021; 24(10): 1083 doi: 10.1089/jmf.2021.K.0069
71
Kimberly Liao, Anthony J. Pellicano, Kai Jiang, Natalia Prakash, Jingsong Li, Shraddha Bhutkar, Zhijian Hu, Quaisar Ali, Itzhak D. Goldberg, Prakash Narayan. Glycerol-3-phosphate Acyltransferase1 Is a Model-Agnostic Node in Nonalcoholic Fatty Liver Disease: Implications for Drug Development and Precision MedicineACS Omega 2020; 5(29): 18465 doi: 10.1021/acsomega.0c02350
72
Hui Emma Zhang, James M. Henderson, Mark D. Gorrell. Animal models for hepatocellular carcinomaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019; 1865(5): 993 doi: 10.1016/j.bbadis.2018.08.009
73
Pavla Staňková, Otto Kučera, Eva Peterová, Moustafa Elkalaf, David Rychtrmoc, Jan Melek, Miroslav Podhola, Veronika Zubáňová, Zuzana Červinková. Western Diet Decreases the Liver Mitochondrial Oxidative Flux of Succinate: Insight from a Murine NAFLD ModelInternational Journal of Molecular Sciences 2021; 22(13): 6908 doi: 10.3390/ijms22136908
74
. Febyan, Norman Delvano Weky. Obesity and Non-Alcoholic Fatty Liver Disease: Pathophysiology and Management FocusedEuropean Journal of Medical and Health Sciences 2021; 3(1): 6 doi: 10.24018/ejmed.2021.3.1.645
75
Anthony J. Pellicano, Kiera Spahn, Ping Zhou, Itzhak D. Goldberg, Prakash Narayan. Collagen Characterization in a Model of Nonalcoholic Steatohepatitis with Fibrosis; A Call for Development of Targeted TherapeuticsMolecules 2021; 26(11): 3316 doi: 10.3390/molecules26113316
76
Jiajie George Lu, Luan Nguyen, Sara Samadzadeh, Maryam Masouminia, Alejandro Mendoza, Owen Sweeney, Brittany Tillman, Nikoo Afifyan, Timothy Morgan, Barbara A. French, Samuel W. French. Expression of proteins upregulated in hepatocellular carcinoma in patients with alcoholic hepatitis (AH) compared to non-alcoholic steatohepatitis (NASH): An immunohistochemical analysis of candidate proteinsExperimental and Molecular Pathology 2018; 104(2): 125 doi: 10.1016/j.yexmp.2018.02.001
77
Annika Rühle, Andrea Boskovic, Adrian T. Billeter, Anne-Catherine Schwarz, Beat P. Müller-Stich. Metabolische Chirurgie, mehr als nur Typ-2-DiabetesAdipositas - Ursachen, Folgeerkrankungen, Therapie 2020; 14(04): 214 doi: 10.1055/a-1267-8215
78
Madalina-Gabriela Taru, Lidia Neamti, Vlad Taru, Lucia Maria Procopciuc, Bogdan Procopet, Monica Lupsor-Platon. How to Identify Advanced Fibrosis in Adult Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Using Ultrasound Elastography—A Review of the Literature and Proposed Multistep ApproachDiagnostics 2023; 13(4): 788 doi: 10.3390/diagnostics13040788
79
Man Hsin Hung, Xin Wei Wang. Hepatocellular CarcinomaMolecular and Translational Medicine 2019; : 293 doi: 10.1007/978-3-030-21540-8_14
80
Daniel Hughes, Aron Hughes, Bilal Al-Sarireh. Hepatocellular carcinoma’s 100 most influential manuscripts: A bibliometric analysisInternational Journal of Hepatobiliary and Pancreatic Diseases 2019; 9(2): 1 doi: 10.5348/100083Z04DH2019OA
81
Ken M. Chin, Mikel Prieto, Chin K. Cheong, Marcello Di Martino, Benedetto Ielpo, Brian K.P. Goh, Ye X. Koh. Outcomes after curative therapy for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: a meta-analysis and review of current literatureHPB 2021; 23(8): 1164 doi: 10.1016/j.hpb.2021.01.009
82
Hui-Ting Chen, Hong-Li Huang, Yong-Qiang Li, Hao-Ming Xu, Yong-Jian Zhou. Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered viewWorld Journal of Gastroenterology 2020; 26(16): 1901-1911 doi: 10.3748/wjg.v26.i16.1901
83
Amir Ajoolabady, Daolin Tang, Guido Kroemer, Jun Ren. Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapyBritish Journal of Cancer 2023; 128(2): 190 doi: 10.1038/s41416-022-01998-x
84
Matthew L. Holzner, Sander Florman, Myron E. Schwartz, Parissa Tabrizian. Outcomes of liver transplantation for nonalcoholic steatohepatitis-associated hepatocellular carcinomaHPB 2022; 24(4): 470 doi: 10.1016/j.hpb.2021.08.943
85
Alicia Bort, Belén Sánchez, Pedro Mateos-Gómez, Inés Díaz-Laviada, Nieves Rodríguez-Henche. Capsaicin Targets Lipogenesis in HepG2 Cells Through AMPK Activation, AKT Inhibition and PPARs RegulationInternational Journal of Molecular Sciences 2019; 20(7): 1660 doi: 10.3390/ijms20071660
86
Pradeep Kumar Rajan, Utibe-Abasi Udoh, Juan D. Sanabria, Moumita Banerjee, Gary Smith, Mathew Steven Schade, Jacqueline Sanabria, Komal Sodhi, Sandrine Pierre, Zijian Xie, Joseph I. Shapiro, Juan Sanabria. The Role of Histone Acetylation-/Methylation-Mediated Apoptotic Gene Regulation in Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2020; 21(23): 8894 doi: 10.3390/ijms21238894
87
Baharan Fekry, Aleix Ribas-Latre, Corrine Baumgartner, Alaa M.T. Mohamed, Mikhail G. Kolonin, Frances M. Sladek, Mamoun Younes, Kristin L. Eckel-Mahan. HNF4α-Deficient Fatty Liver Provides a Permissive Environment for Sex-Independent Hepatocellular CarcinomaCancer Research 2019; 79(22): 5860 doi: 10.1158/0008-5472.CAN-19-1277
88
Monika Pazgan-Simon, Michał Kukla, Jolanta Zuwała-Jagiełło, Aleksandra Derra, Martyna Bator, Tomasz Menżyk, Andrzej Lekstan, Ewa Grzebyk, Krzysztof Simon, Matias A. Avila. Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC)PLOS ONE 2020; 15(1): e0227459 doi: 10.1371/journal.pone.0227459
89
Ying Qi Goh, Guoxiang Cheam, Yulan Wang. Understanding Choline Bioavailability and Utilization: First Step Toward Personalizing Choline NutritionJournal of Agricultural and Food Chemistry 2021; 69(37): 10774 doi: 10.1021/acs.jafc.1c03077
90
Lung-Yi Mak, Vania Cruz-Ramón, Paulina Chinchilla-López, Harrys A. Torres, Noelle K. LoConte, John P. Rice, Lewis E. Foxhall, Erich M. Sturgis, Janette K. Merrill, Howard H. Bailey, Nahum Méndez-Sánchez, Man-Fung Yuen, Jessica P. Hwang. Global Epidemiology, Prevention, and Management of Hepatocellular CarcinomaAmerican Society of Clinical Oncology Educational Book 2018; (38): 262 doi: 10.1200/EDBK_200939
91
Evangelista Sagnelli, Margherita Macera, Antonio Russo, Nicola Coppola, Caterina Sagnelli. Epidemiological and etiological variations in hepatocellular carcinomaInfection 2020; 48(1): 7 doi: 10.1007/s15010-019-01345-y
92
Luke V. Selby, Aslam Ejaz, Stacy A. Brethauer, Timothy M. Pawlik. Fatty liver disease and primary liver cancer: disease mechanisms, emerging therapies and the role of bariatric surgeryExpert Opinion on Investigational Drugs 2020; 29(2): 107 doi: 10.1080/13543784.2020.1721457
93
Takao Watanabe, Takeshi Imamura, Yoichi Hiasa. Roles of protein kinase R in cancer: Potential as a therapeutic targetCancer Science 2018; 109(4): 919 doi: 10.1111/cas.13551
94
Kheng Song Leow, Christine Ying Kwok, Hsien Min Low, Rahul Lohan, Tze Chwan Lim, Su Chong Albert Low, Cher Heng Tan. Algorithm‐based approach to focal liver lesions in contrast‐enhanced ultrasoundAustralasian Journal of Ultrasound in Medicine 2022; 25(3): 142 doi: 10.1002/ajum.12306
95
Heejun Son, Bo Kyung Koo, Sae Kyung Joo, Dong Hyeon Lee, Heejoon Jang, Jeong Hwan Park, Mee Soo Chang, Won Kim. PNPLA3 genotypes modify the adverse effect of the total energy intake on high-risk nonalcoholic steatohepatitis developmentThe American Journal of Clinical Nutrition 2023; 117(5): 910 doi: 10.1016/j.ajcnut.2023.02.024
96
Ryan Lamm, Peter J. Altshuler, Keyur Patel, Osama Shaheen, Angel Paulo Amante, Jesse Civan, Warren Maley, Adam Frank, Carlo Ramirez, Jaime Glorioso, Ashesh Shah, Hien Dang, Adam S. Bodzin. Reduced Rates of Post-Transplant Recurrent Hepatocellular Carcinoma in Non-Alcoholic Steatohepatitis: A Propensity Score Matched AnalysisTransplant International 2022; 35 doi: 10.3389/ti.2022.10175
97
Claire E. Thomas, Hung N. Luu, Renwei Wang, Jennifer Adams-Haduch, Aizhen Jin, Woon-Puay Koh, Jian-Min Yuan. Association between Dietary Tomato Intake and the Risk of Hepatocellular Carcinoma: The Singapore Chinese Health StudyCancer Epidemiology, Biomarkers & Prevention 2020; 29(7): 1430 doi: 10.1158/1055-9965.EPI-20-0051
98
Eva Lieto, Gennaro Galizia, Francesca Cardella, Andrea Mabilia, Nicoletta Basile, Paolo Castellano, Michele Orditura, Annamaria Auricchio. Indocyanine Green Fluorescence Imaging-Guided Surgery in Primary and Metastatic Liver TumorsSurgical Innovation 2018; 25(1): 62 doi: 10.1177/1553350617751451
99
Byeonggeun Kang, Byunghee Kang, Tae-Young Roh, Rho Hyun Seong, Won Kim. The Chromatin Accessibility Landscape of Nonalcoholic Fatty Liver Disease ProgressionMolecules and Cells 2022; 45(5): 343 doi: 10.14348/molcells.2022.0001
100
Yuichiro Eguchi, Gabriel Wong, I‐Heng Lee, Omar Akhtar, Ricardo Lopes, Yoshio Sumida. Hepatocellular carcinoma and other complications of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in Japan: A structured review of published worksHepatology Research 2021; 51(1): 19 doi: 10.1111/hepr.13583
101
Zobair M. Younossi, Linda Henry. Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinomaJHEP Reports 2021; 3(4): 100305 doi: 10.1016/j.jhepr.2021.100305
102
Douglas G. Mashek, Wenqi Cui, Linshan Shang, Charles P. Najt. The Liver2020; : 245 doi: 10.1002/9781119436812.ch21
103
Danny Orabi, Nathan A. Berger, J. Mark Brown. Abnormal Metabolism in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic Insights to ChemopreventionCancers 2021; 13(14): 3473 doi: 10.3390/cancers13143473
104
Meenakshi Vachher, Savita Bansal, Bhupender Kumar, Sandeep Yadav, Taruna Arora, Nalini Moza Wali, Archana Burman. Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinomaJournal of Cellular Biochemistry 2022; 123(10): 1553 doi: 10.1002/jcb.30252
105
Xu Li, Xiaocong Wang, Pujun Gao. Diabetes Mellitus and Risk of Hepatocellular CarcinomaBioMed Research International 2017; 2017: 1 doi: 10.1155/2017/5202684
106
Hailey H. Choi, Shuchi K. Rodgers, Aman Khurana, Leslie W. Nelson, Aya Kamaya. Role of Ultrasound for Chronic Liver Disease and Hepatocellular Carcinoma SurveillanceMagnetic Resonance Imaging Clinics of North America 2021; 29(3): 279 doi: 10.1016/j.mric.2021.05.005
107
Yue Jia, Ping Ji, Barbara French, Brittany Tillman, Samuel W. French. The different expression of tumor suppressors, RASSF1A, RUNX3, and GSTP1, in patients with alcoholic steatohepatitis (ASH) vs non-alcoholic steatohepatitis (NASH)Experimental and Molecular Pathology 2019; 108: 156 doi: 10.1016/j.yexmp.2019.04.002
108
Maria Corina Plaz Torres, Ariel Jaffe, Rachel Perry, Elisa Marabotto, Mario Strazzabosco, Edoardo G. Giannini. Diabetes medications and risk of HCCHepatology 2022; 76(6): 1880 doi: 10.1002/hep.32439
109
Eman D. Mohammed, Ashraf B. Abdel-Naim, Jin Kangpeng, Runqiu Jiang, Jifu Wei, Beicheng Sun. The mother relationship between insulin resistance and non-alcoholic steatohepatitis: Glucosinolates hydrolysis products as a promising insulin resistance-modulator and fatty liver-preventerLife Sciences 2021; 264: 118615 doi: 10.1016/j.lfs.2020.118615
110
Nikolaus Berndt, Johannes Eckstein, Niklas Heucke, Robert Gajowski, Martin Stockmann, David Meierhofer, Hermann-Georg Holzhütter. Characterization of Lipid and Lipid Droplet Metabolism in Human HCCCells 2019; 8(5): 512 doi: 10.3390/cells8050512
111
José M Mato, Cristina Alonso, Mazen Noureddin, Shelly C Lu. Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2019; 25(24): 3009-3020 doi: 10.3748/wjg.v25.i24.3009
112
Hyunmi Kim, Da Som Lee, Tae Hyeon An, Hyun-Ju Park, Won Kon Kim, Kwang-Hee Bae, Kyoung-Jin Oh. Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCCInternational Journal of Molecular Sciences 2021; 22(9): 4495 doi: 10.3390/ijms22094495
113
Frederico Costa, Bertram Wiedenmann, Christoph Roderburg, Raphael Mohr, Ghassan K. Abou‐Alfa. Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinomaCancer Medicine 2023;  doi: 10.1002/cam4.6033